Highbridge Capital Management’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Highbridge Capital Management’s Portfolio INFI Stock Details INFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-29,900	Closed	-$40K	–	1758
2016 Q2	$40K	Sell	29,900 -23,400	-44%	-$109K	﹤0.01%	1334
2016 Q1	$281K	Buy	53,300 +30,000	+129%	+$184K	﹤0.01%	1203
2015 Q4	$183K	Sell	23,300 -186,300	-89%	-$1.6M	﹤0.01%	1365
2015 Q3	$1.77M	Buy	+209,600	New	+$1.93M	0.03%	582
2014 Q4	–	Sell	-66,900	Closed	-$898K	–	1492
2014 Q3	$898K	Buy	+66,900	New	+$797K	0.01%	700
2013 Q3	–	Sell	-13,800	Closed	-$223K	–	1574
2013 Q2	$223K	Buy	+13,800	New	+$427K	﹤0.01%	1141

Other funds holding INFI

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

FCMI

Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return

Highbridge Capital Management's INFI Position: Q2 2017 in Review

Highbridge Capital Management sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q2 2017, closing a stake of 32,793 shares — an estimated $106K sold.

Highbridge Capital Management first reported a position in INFI in Q2 2013 and held it in 6 quarters. The position peaked at $2.06M in Q2 2013. 74 funds tracked by Wall St. Rank hold INFI as of Q2 2017.

Highbridge Capital Management reported no remaining Infinity Pharmaceuticals, Inc. position as of Q2 2017 after selling out during the quarter.
Highbridge Capital Management sold 32,793 Infinity Pharmaceuticals, Inc. shares in Q2 2017, an estimated $106K.
Highbridge Capital Management first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2013 and held it in 6 quarters.
Highbridge Capital Management's Infinity Pharmaceuticals, Inc. position peaked at $2.06M in Q2 2013.
74 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q2 2017.

Based on Highbridge Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.